The role of gut microbiome in modulating response to immune checkpoint inhibitor therapy in cancer

by Naqash, Abdul Rafeh, Kihn-Alarcón, Alba J., Stavraka, Chara, Kerrigan, Kathleen, Maleki Vareki, Saman, Pinato, David James, Puri, Sonam
Published in Ann Transl Med (2021)

Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options

by Personeni, Nicola, Lleo, Ana, Pressiani, Tiziana, Colapietro, Francesca, Openshaw, Mark Robert, Stavraka, Chara, Pouptsis, Athanasios, Pinato, David James, Rimassa, Lorenza
Published in Cancers (Basel) (2020)

Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study

by Yen, Clarence, Sharma, Rohini, Rimassa, Lorenza, Arizumi, Tadaaki, Bettinger, Dominik, Choo, Huay Yee, Pressiani, Tiziana, Burlone, Michela E., Pirisi, Mario, Giordano, Laura, Abdulrahman, Anisa, Kudo, Masatoshi, Thimme, Robert, Park, Joong Won, Pinato, David James
Published in Liver Cancer (2017)

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

by Cortellini, Alessio, Tucci, Marco, Adamo, Vincenzo, Stucci, Luigia Stefania, Russo, Alessandro, Tanda, Enrica Teresa, Spagnolo, Francesco, Rastelli, Francesca, Bisonni, Renato, Santini, Daniele, Russano, Marco, Anesi, Cecilia, Giusti, Raffaele, Filetti, Marco, Marchetti, Paolo, Botticelli, Andrea, Gelibter, Alain, Occhipinti, Mario Alberto, Marconcini, Riccardo, Vitale, Maria Giuseppa, Nicolardi, Linda, Chiari, Rita, Bareggi, Claudia, Nigro, Olga, Tuzi, Alessandro, De Tursi, Michele, Petragnani, Nicola, Pala, Laura, Bracarda, Sergio, Macrini, Serena, Inno, Alessandro, Zoratto, Federica, Veltri, Enzo, Di Cocco, Barbara, Mallardo, Domenico, Vitale, Maria Grazia, Pinato, David James, Porzio, Giampiero, Ficorella, Corrado, Ascierto, Paolo Antonio
Published in J Immunother Cancer (2020)